BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1838256)

  • 1. [Treatment of seborrhoeic eczema with ketoconazole in comparison with an active agent-free cream].
    Peter RU; Korting HC
    Arzneimittelforschung; 1991 Aug; 41(8):852-4. PubMed ID: 1838256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
    Seckin D; Gurbuz O; Akin O
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial.
    Elewski B; Ling MR; Phillips TJ
    J Drugs Dermatol; 2006; 5(7):646-50. PubMed ID: 16865870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis.
    Squire RA; Goode K
    J Dermatolog Treat; 2002 Jun; 13(2):51-60. PubMed ID: 12060502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind trial of treatment of seborrhoeic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream.
    Katsambas A; Antoniou C; Frangouli E; Avgerinou G; Michailidis D; Stratigos J
    Br J Dermatol; 1989 Sep; 121(3):353-7. PubMed ID: 2529893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis.
    Ratnavel RC; Squire RA; Boorman GC
    J Dermatolog Treat; 2007; 18(2):88-96. PubMed ID: 17520465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
    Elewski BE; Abramovits W; Kempers S; Schlessinger J; Rosen T; Gupta AK; Abraham S; Rowell R
    J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole.
    Green CA; Farr PM; Shuster S
    Br J Dermatol; 1987 Feb; 116(2):217-21. PubMed ID: 2950915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of seborrhoeic dermatitis with ketoconazole: I. Response of seborrhoeic dermatitis of the scalp to topical ketoconazole.
    Carr MM; Pryce DM; Ive FA
    Br J Dermatol; 1987 Feb; 116(2):213-6. PubMed ID: 2950914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transcutaneous absorption of ketoconazole in infant after application of Ketoderm].
    Levron JC; Taieb A
    Therapie; 1991; 46(1):29-31. PubMed ID: 1826971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis.
    Koc E; Arca E; Kose O; Akar A
    J Dermatolog Treat; 2009; 20(1):4-9. PubMed ID: 18677657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis.
    Swinyer LJ; Decroix J; Langner A; Quiring JN; Blockhuys S
    Cutis; 2007 Jun; 79(6):475-82. PubMed ID: 17713152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised double blind controlled trial of 2% ketoconazole cream versus 0.05% clobetasol 17-butyrate cream in seborrhoeic dermatitis.
    Pari T; Pulimood S; Jacob M; George S; Jeyaseelan L; Thomas K
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):89-90. PubMed ID: 9552768
    [No Abstract]   [Full Text] [Related]  

  • 16. Ketoconazole in the treatment of blepharitis.
    Nelson ME; Midgley G; Blatchford NR
    Eye (Lond); 1990; 4 ( Pt 1)():151-9. PubMed ID: 2138985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream.
    Skinner RB; Noah PW; Taylor RM; Zanolli MD; West S; Guin JD; Rosenberg EW
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):852-6. PubMed ID: 3159759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis.
    Wannanukul S; Chiabunkana J
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S68-71. PubMed ID: 16083165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical ketoconazole for infantile seborrhoeic dermatitis.
    Taieb A; Legrain V; Palmier C; Lejean S; Six M; Maleville J
    Dermatologica; 1990; 181(1):26-32. PubMed ID: 2144249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. A double-blind comparative study.
    Stratigos JD; Antoniou C; Katsambas A; Böhler K; Fritsch P; Schmölz A; Michaelidis D; De Beule K
    J Am Acad Dermatol; 1988 Nov; 19(5 Pt 1):850-3. PubMed ID: 2973476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.